Patents by Inventor Michael Keefer

Michael Keefer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Console for retractable roofs and facades
    Patent number: 12421721
    Abstract: The invention relates to a console with the aid of which large roofs and facade elements can be horizontally or vertically retracted.
    Type: Grant
    Filed: August 12, 2022
    Date of Patent: September 23, 2025
    Assignee: Delta-X GmbH Ingenieurgesellschaft
    Inventors: Albrecht Burmeister, Lutz Eitel, Michael Keefer
  • Console for retractable roofs and facades
    Patent number: 12152386
    Abstract: The invention relates to a console with the aid of which large roofs and facade elements can be horizontally or vertically retracted.
    Type: Grant
    Filed: August 12, 2022
    Date of Patent: November 26, 2024
    Assignee: Delta-X GmbH Ingenieurgesellschaft
    Inventors: Albrecht Burmeister, Lutz Eitel, Michael Keefer
  • Console for retractable roofs and facades
    Publication number: 20240368882
    Abstract: The invention relates to a console with the aid of which large roofs and facade elements can be horizontally or vertically retracted.
    Type: Application
    Filed: August 12, 2022
    Publication date: November 7, 2024
    Applicant: Delta-X GmbH Ingenieurgesellschaft
    Inventors: Albrecht Burmeister, Lutz Eitel, Michael Keefer
  • Console for retractable roofs and facades
    Publication number: 20240263446
    Abstract: The invention relates to a console with the aid of which large roofs and facade elements can be horizontally or vertically retracted.
    Type: Application
    Filed: August 12, 2022
    Publication date: August 8, 2024
    Applicant: Delta-X GmbH Ingenieurgesellschaft
    Inventors: Albrecht Burmeister, Lutz Eitel, Michael Keefer
  • Broadly neutralizing anti-influenza human monoclonal antibody and uses thereof
    Patent number: 11168129
    Abstract: The present invention relates to broadly neutralizing anti-influenza monoclonal antibodies or antigen-binding fragments thereof. The present invention further relates to therapeutic uses of the isolated antibody or the antigen-binding fragment thereof.
    Type: Grant
    Filed: May 10, 2018
    Date of Patent: November 9, 2021
    Assignee: University of Rochester
    Inventors: James J. Kobie, Michael Piepenbrink, Michael Keefer, Luis Martinez-Sobrido, Aitor Nogales
  • Broadly Neutralizing Anti-Influenza Human Monoclonal Antibody and Uses Thereof
    Publication number: 20200140526
    Abstract: The present invention relates to broadly neutralizing anti-influenza monoclonal antibodies or antigen-binding fragments thereof. The present invention further relates to therapeutic uses of the isolated antibody or the antigen-binding fragment thereof.
    Type: Application
    Filed: May 10, 2018
    Publication date: May 7, 2020
    Applicant: University of Rochester
    Inventors: James J. Kobie, Michael Piepenbrink, Michael Keefer, Luis Martinez-Sobrido, Aitor Nogales